Page results
-
UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.
-
The North Central London Integrated Care System (NCL ICS) has new services and staff training to support patients with inherited red cell disorders, including Sickle Cell and Thalassaemia, living in Barnet, Camden, Enfield, Haringey and Islington.
-
This information is for patients receiving steroids for immunotherapy toxicity.
-
A new NHS vaccination centre at UCL’s Bidborough House, Bidborough Street, WC1H 9BT opened 26 August 2021.
-
An antibody treatment trialled at UCLH cuts the risk of developing symptomatic COVID-19 by 77%.
-
Breathing aids developed by engineers at UCL, UCLH and Mercedes-AMG High Performance Powertrains have been delivered to 40 NHS hospitals across the country.
-
Patients recovering from coronavirus have spoken movingly about the physical and emotional legacy of the disease.
-
Information on the insertion of an inflatable penile prosthesis
-
The special haematology service provides a comprehensive investigation of haemolytic amaemia, haemoglobinopathies and red cell enzymopathy.
-
Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.
File results
-
FOI/2024/0458 - Infected blood products, patient numbers 2019/20-2023/24
-
FOI/2024/0577 - Diffuse Large B Cell Lymphoma treatments
-
FOI/2024/0578 - Public identity insurance policies held by Fertility Clinic that cover data breaches
-
FOI/2024/0580 - Newborns taken into care from the maternity wards 2019-2023
-
FOI/2024/0581 - Weight management services/ bariatric surgery/ access to Wegovy
-
FOI/2024/0582 - SACT (systemic anti-cancer therapy) treatments for endometrial cancer
-
FOI/2024/0583 - National inpatient survey improvements/ night-time noise levels/ ward lighting/ mealtime support
-
FOI/2024/0584 - Immunology Hidradenitis Suppurativa (HS) treatments
-
FOI/2024/0586 - Subject Access Requests (SAR) and Freedom of Information (FOI) requests for 2023/24
-
FOI/2024/0587 - Colorectal cancer treatments